Search





Search





Markets
/
Stocks
/
apre
/

Aprea Therapeutics Inc

APRE

Add to Watchlist

0.632USD

+0.004+0.70%

Close 07-24 16:00（ET）Quotes delayed by 15 min

7.57MMarket Cap

LossP/E TTM

Aprea Therapeutics Inc

0.632

+0.004+0.70%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

APRE Cash Flow Statement

You can access the annual and quarterly cash flow statements of Aprea Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

24.08%-2.76M

15.65%-2.96M

-28.48%-3.17M

14.03%-3.13M

7.74%-3.63M

6.12%-3.51M

-10.10%-2.47M

-13.20%-3.64M

-32.12%-3.94M

6.99%-3.74M

65.99%-2.24M

63.87%-3.22M

45.79%-2.98M

60.50%-4.02M

19.93%-6.59M

-14.84%-8.90M

52.31%-5.50M

22.88%-10.18M

27.93%-8.23M

19.57%-7.75M

-52.78%-11.52M

-25.73%-13.20M

-308.96%-11.42M

-93.72%-9.64M

-79.68%-7.54M

-172.59%-10.50M

11.38%-2.79M

---4.98M

---4.20M

---3.85M

---3.15M

Net income from continuing operations

16.39%-3.29M

15.17%-2.46M

21.44%-2.97M

6.66%-3.24M

-39.95%-3.93M

15.93%-2.89M

-18.08%-3.78M

-6.47%-3.47M

35.84%-2.81M

-40.99%-3.44M

20.38%-3.20M

96.68%-3.26M

44.81%-4.38M

68.51%-2.44M

57.42%-4.02M

-858.52%-98.26M

17.91%-7.94M

49.62%-7.76M

23.26%-9.45M

37.37%-10.25M

-2.86%-9.67M

-17.75%-15.39M

-97.11%-12.32M

-211.03%-16.37M

-170.50%-9.40M

-179.35%-13.07M

-99.14%-6.25M

---5.26M

---3.48M

---4.68M

---3.14M

Operating gains losses

-0.02%5.43K

0.02%5.43K

0.00%5.43K

2.34%5.43K

-11.82%5.43K

8.86%5.43K

279.12%5.43K

2267.86%5.30K

1401.71%6.16K

--4.99K

1073.77%1.43K

-93.98%224.00

-86.06%410.00

-100.00%0.00

-99.82%122.00

-93.82%3.72K

-96.13%2.94K

15.99%65.99K

22.50%69.44K

24.83%60.24K

12.14%76.00K

9.72%56.89K

-8.28%56.69K

68.32%48.26K

142.72%67.77K

2788.86%51.85K

2637.25%61.81K

--28.67K

--27.92K

--1.79K

--2.26K

Other non-cash items

-114.89%-7.71K

221.86%47.75K

-83.97%5.69K

429.33%29.12K

192.22%51.80K

-149.85%-39.19K

1132.43%35.49K

109.76%5.50K

-507.16%-56.18K

151.87%78.61K

-92.19%2.88K

-100.08%-56.36K

118.30%13.80K

144.48%31.21K

68.41%36.89K

28545.72%72.43M

85.56%-75.39K

-105.98%-70.17K

-70.62%21.91K

-86.62%252.84K

76.78%-521.98K

-7.05%1.17M

107.65%74.56K

377.87%1.89M

-140.18%-2.25M

674.81%1.26M

-569.80%-975.03K

---680.06K

---935.92K

---219.70K

--207.54K

Change in working capital

244.19%432.41K

5.72%-667.87K

-128.76%-323.69K

79.68%-63.16K

110.82%125.63K

-53.04%-708.38K

27.57%1.13M

-81.80%-310.86K

-184.77%-1.16M

72.23%-462.86K

133.38%882.21K

-108.06%-170.99K

218.87%1.37M

63.04%-1.67M

-190.78%-2.64M

557.82%2.12M

113.31%429.75K

-861.97%-4.51M

-45.13%-908.99K

-90.88%322.55K

-203.08%-3.23M

-205.34%-468.88K

-115.19%-626.35K

370.48%3.54M

3464.47%3.13M

-53.96%445.13K

1458.70%4.12M

--751.40K

--87.90K

--966.76K

---303.46K

-Change in prepaid expenses

0.40%181.78K

-48.55%-735.65K

-72.66%170.00K

138.15%166.71K

-15.26%181.04K

20.79%-495.20K

-6.76%621.83K

-760.13%-436.94K

-37.91%213.64K

35.98%-625.14K

-35.85%666.89K

-93.46%66.19K

-69.15%344.06K

64.59%-976.42K

39.83%1.04M

3.97%1.01M

19.72%1.12M

-27.00%-2.76M

240.84%743.52K

58.03%972.99K

7.70%931.58K

16.06%-2.17M

427.05%218.15K

1711.49%615.72K

1393.10%864.94K

-2398.50%-2.59M

-795.33%-66.70K

---38.21K

--57.93K

---103.53K

---7.45K

-Change in other current liabilities

----

-100.00%0.00

---50.74K

---97.67K

---380.57K

--528.97K

----

--4.24M

----

--0.00

Cash from non-recurring investing activities

Cash from operating activities

24.08%-2.76M

15.65%-2.96M

-28.48%-3.17M

14.03%-3.13M

7.74%-3.63M

6.12%-3.51M

-10.10%-2.47M

-13.20%-3.64M

-32.12%-3.94M

6.99%-3.74M

65.99%-2.24M

63.87%-3.22M

45.79%-2.98M

60.50%-4.02M

19.93%-6.59M

-14.84%-8.90M

52.31%-5.50M

22.88%-10.18M

27.93%-8.23M

19.57%-7.75M

-52.78%-11.52M

-25.73%-13.20M

-308.96%-11.42M

-93.72%-9.64M

-79.68%-7.54M

-172.59%-10.50M

11.38%-2.79M

---4.98M

---4.20M

---3.85M

---3.15M

Investing cash flow

Net cash from continuing investing activities

----

-100.00%0.00

--7.50K

--7.98K

--7.15K

--85.94K

----

--0.00

-100.00%0.00

100.00%0.00

-100.00%0.00

12.61%16.29K

-107.08%-725.00

-132.65%-2.02K

--12.16K

1899.25%14.47K

4593.86%10.25K

--6.19K

--0.00

---804.00

---228.00

Capital expenditures

----

-100.00%0.00

--7.50K

--7.98K

--7.15K

--85.94K

----

--0.00

-100.00%0.00

--0.00

-100.00%0.00

12.61%16.29K

----

--12.16K

--14.47K

--10.25K

--6.19K

--0.00

----

Net cash flow from disposal of fixed assets

----

-100.00%0.00

--7.50K

--7.98K

--7.15K

--85.94K

----

--0.00

-100.00%0.00

100.00%0.00

-100.00%0.00

12.61%16.29K

-107.08%-725.00

-132.65%-2.02K

--12.16K

1899.25%14.47K

4593.86%10.25K

--6.19K

--0.00

---804.00

---228.00

Cash from non-current investing activities

Net cash flow from investing activities

----

100.00%0.00

---7.50K

---7.98K

---7.15K

---85.94K

----

--0.00

100.00%0.00

-100.00%0.00

100.00%0.00

-12.61%-16.29K

107.08%725.00

132.65%2.02K

---12.16K

-1899.25%-14.47K

-4593.86%-10.25K

---6.19K

--0.00

--804.00

--228.00

Financing cash flow

Cash flow from continuous financing activities

61896.01%34.62M

2758.20%3.84M

31090.48%357.94K

1927.54%384.88K

-99.62%55.85K

--134.41K

---1.16K

---21.06K

186.18%14.71M

-100.00%0.00

--0.00

--5.14M

-94.06%98.53K

572.01%584.45K

--0.00

--1.66M

--86.97K

-100.00%0.00

100.00%0.00

127.86%121.43K

-99.46%29.52K

54.27%86.95M

---3.62M

---435.80K

--5.43M

--56.37M

--0.00

Net cash flow from common stock issuance/repurchase

59154.50%35.10M

2893.23%4.21M

--375.38K

--399.79K

-99.63%59.23K

--140.76K

--0.00

176.38%16.00M

----

-100.00%0.00

--0.00

--5.79M

-93.60%98.53K

--584.45K

----

--1.54M

----

-100.00%0.00

----

--86.91M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

----

-100.00%0.00

--0.00

--5.60M

--56.36M

--0.00

Proceeds from stock option exercised by employees

----

-100.00%0.00

--0.00

--121.40K

--86.97K

-100.00%0.00

--0.00

--121.43K

27.71%29.52K

6920.38%47.88K

--0.00

--23.12K

--682.00

--0.00

Proceeds from issuance of warrants

----

--91.00

----

Net cash flow from other financing activities

-13922.57%-474.66K

-5751.25%-371.73K

-1409.78%-17.44K

29.22%-14.91K

99.74%-3.38K

---6.35K

---1.16K

---21.06K

-98.77%-1.29M

--0.00

---648.93K

----

---3.62M

---435.80K

---188.83K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

61896.01%34.62M

2758.20%3.84M

31090.48%357.94K

1927.54%384.88K

-99.62%55.85K

--134.41K

---1.16K

---21.06K

186.18%14.71M

-100.00%0.00

--0.00

--5.14M

-94.06%98.53K

572.01%584.45K

--0.00

--1.66M

--86.97K

-100.00%0.00

100.00%0.00

127.86%121.43K

-99.46%29.52K

54.27%86.95M

---3.62M

---435.80K

--5.43M

--56.37M

--0.00

Net cash flow

Beginning cash balance

-36.04%14.64M

-47.67%13.76M

-42.33%16.57M

-40.40%19.32M

5.74%22.89M

3.53%26.29M

3.65%28.74M

4.57%32.41M

-24.80%21.65M

-23.31%25.39M

-29.02%27.73M

-34.95%31.00M

-45.76%28.79M

-46.10%33.11M

-44.04%39.06M

-38.61%47.65M

-40.38%53.08M

-39.27%61.43M

-38.15%69.80M

-36.65%77.62M

-31.57%89.02M

93.27%101.15M

85.03%112.86M

86.52%122.51M

98.08%130.09M

323.62%52.33M

290.89%60.99M

--65.68M

--12.35M

--15.60M

Current period cash flow changes

991.66%31.87M

125.92%881.55K

-15.10%-2.81M

25.35%-2.74M

-133.20%-3.57M

9.22%-3.40M

-4.87%-2.44M

-12.37%-3.68M

387.24%10.76M

13.40%-3.75M

60.82%-2.33M

61.92%-3.27M

140.73%2.21M

48.21%-4.33M

28.96%-5.95M

-9.95%-8.59M

52.43%-5.42M

31.14%-8.35M

28.51%-8.38M

19.06%-7.81M

-50.51%-11.40M

-115.60%-12.13M

-35.27%-11.71M

-105.89%-9.65M

-114602.90%-7.58M

45.82%77.75M

-166.49%-8.66M

---4.69M

--6.62K

--53.32M

---3.25M

Effect of exchange rate changes

-124.89%-348.00

105.17%1.27K

-102.43%-600.00

154.06%2.61K

157.91%1.40K

-6525.07%-24.61K

816.80%24.66K

90.98%-4.82K

-105.01%-2.41K

100.09%383.00

-105.89%-3.44K

-117.08%-53.50K

-32.22%48.16K

-342.78%-403.97K

125.51%58.42K

619.10%313.25K

-41.03%71.05K

-84.69%166.39K

21.59%-229.01K

55.95%-60.35K

335.13%120.49K

-17.28%1.09M

86.95%-292.06K

-118.77%-136.99K

95.83%-51.24K

62.77%1.31M

-2181.99%-2.24M

--729.65K

---1.23M

--806.97K

---98.05K

Ending cash balance

140.77%46.51M

-36.04%14.64M

-47.67%13.76M

-42.33%16.57M

-40.40%19.32M

5.74%22.89M

3.53%26.29M

3.65%28.74M

4.57%32.41M

-24.80%21.65M

-23.31%25.39M

-29.02%27.73M

-34.95%31.00M

-45.76%28.79M

-46.10%33.11M

-44.04%39.06M

-38.61%47.65M

-40.38%53.08M

-39.27%61.43M

-38.15%69.80M

-36.65%77.62M

-31.57%89.02M

93.27%101.15M

85.03%112.86M

86.52%122.51M

98.08%130.09M

323.62%52.33M

--60.99M

--65.68M

--12.35M

Free cash flow

----

6.30%-3.51M

-6.03%-2.47M

---3.65M

---3.94M

6.81%-3.75M

64.69%-2.33M

----

60.50%-4.02M

19.93%-6.59M

-14.84%-8.90M

52.31%-5.50M

22.98%-10.18M

27.93%-8.23M

19.57%-7.75M

-52.53%-11.52M

-25.71%-13.22M

-307.47%-11.42M

-93.48%-9.64M

-79.97%-7.55M

---10.51M

---2.80M

---4.98M

---4.20M

----

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Aprea Therapeutics Inc Generate?



Aprea Therapeutics Inc generated -12.89M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Aprea Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Aprea Therapeutics Inc's operating cash flow increased by 4.89% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Aprea Therapeutics Inc's Financing Cash Flow Changed?



Aprea Therapeutics Inc used 4.64M in financing activities in the latest quarter.

What is free cash flow and why does it matter for APRE?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.